NRD135S.E1

· Novaremed Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NRD135S.E1, covering 2016-09-22 to 2016-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients [Phase 2]